Search
for

    Research 10 of 1000+

    1. No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study Journal of the American Academy of Dermatology · 2026
    2. [Efficacy and cardiovascular tolerability of minotricon in the treatment of seborrheic alopecia]. PubMed · 1990
    3. 42276 Long-Term Safety of Ixekizumab Treatment in Adult Patients with Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: A Post-hoc Analysis of End-Of-Study Program Data Relating to Major Adverse Cardiovascular Events Journal of the American Academy of Dermatology · 2023
    4. Supplemental Materials for "No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study" Mendeley Data · 2026
    5. Supplemental Materials for "No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study" Mendeley Data · 2026
    6. Supplemental Materials for "No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study" Mendeley Data · 2026
    7. The hydroxypropyl‐β‐cyclodextrin‐minoxidil inclusion complex improves the cardiovascular and proliferative adverse effects of minoxidil in male rats: Implications in the treatment of alopecia Pharmacology Research & Perspectives · 2020 · 6 citations
    8. Non-Invasive Quick Diagnosis of Cardiovascular Problems from Visible and Invisible Abnormal Changes with Increased Cardiac Troponin I Appearing On Cardiovascular Representation Areas of the Eyebrows, Left Upper Lip, etc. of the Face & Hands: Beneficial Manual Stimulation of Hands for Acute Anginal Chest Pain, and Important Factors in Safe, Effective Treatment Acupuncture & electro-therapeutics research · 2014
    9. Scientific Opinion on the substantiation of health claims related to soy isoflavones and protection of DNA, proteins and lipids from oxidative damage (ID 1286, 4245), maintenance of normal blood LDL cholesterol concentrations (ID 1135, 1704a, 3093a), reduction of vasomotor symptoms associated with menopause (ID 1654, 1704b, 2140, 3093b, 3154, 3590), maintenance of normal skin tonicity (ID 1704a), contribution to normal hair growth (ID 1704a, 4254), “cardiovascular health” (ID 3587), treatment … EFSA journal · 2011 · 22 citations
    10. Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline The Journal of Clinical Endocrinology & Metabolism · 2009 · 855 citations
    All research results →

    Community 10 of 21

    1. RU58841 - Has anyone tried it before? Reddit · 30 Apr 2026
    2. The Fear of Oral Minoxidil is Overblown Reddit · 25 Jun 2025
    3. Pattern hair loss before the age of 35 is associated with higher chances of prostate cancer, cardiovascular diseases, and metabolic syndrome later in life Reddit · 7 Jun 2026
    4. To everyone who cant use FIN and doesnt want to use RU Reddit · 19 Aug 2024
    5. Has anyone ever tried nandrolone to regrow hair? Reddit · 21 Jul 2025
    6. Is there a consensus on RU these days? Pyril turned out to be a bust right? Reddit · 13 Mar 2024
    7. Why is it "not right" to start off with Dutasteride? Reddit · 3 Jul 2024
    8. "Things are now in motion that cannot be undone." First Fin tablet taken today. Reddit · 29 Jul 2024
    9. Finasteride is Good for Heart Health! Reddit · 21 Feb 2024
    10. How much hair did the obese people in the 1980s get on 50mg+ of oral minxodil? Reddit · 17 Sept 2026
    All community results →

    Learn 4

    1. Estradiol Estrogen hormone, prescribed in tablet, patch and gel forms
    2. Tofacitinib JAK inhibitor pill, an immune-system drug
    3. Vitamin D Vitamin made in the skin from sunlight, also taken as a supplement
    4. Baricitinib JAK inhibitor pill used for severe alopecia areata